Neoadjuvant Chemoradiotherapy improves oncological results in resectable and borderline resectable Pancreatic Carcinomas, but not Overall Survival in resectable ones Results of the Dutch PREOPANC Study

被引：0
|
作者：
Hermann, Robert Michael [1 ]
Christiansen, Hans [2 ]
机构：
[1] Zentrum Strahlentherapie, Mozartstr 30, D-26655 Westerstede, Germany
[2] Hannover Med Sch, Klin Strahlentherapie & Spezielle Onkol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2021年 / 197卷 / 01期
关键词：
GEMCITABINE;
D O I：
10.1007/s00066-020-01717-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 88
页数：4
相关论文
共 50 条
  • [1] Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
    Versteijne, Eva
    van Dam, Jacob L.
    Suker, Mustafa
    Janssen, Quisette P.
    Groothuis, Karin
    Akkermans-Vogelaar, Janine M.
    Besselink, Marc G.
    Bonsing, Bert A.
    Buijsen, Jeroen
    Busch, Olivier R.
    Creemers, Geert-Jan M.
    van Dam, Ronald M.
    Eskens, Ferry A. L. M.
    Festen, Sebastiaan
    de Groot, Jan Willem B.
    Koerkamp, Bas Groot
    de Hingh, Ignace H.
    Homs, Marjolein Y., V
    van Hooft, Jeanin E.
    Kerver, Emile D.
    Luelmo, Saskia A. C.
    Neelis, Karen J.
    Nuyttens, Joost
    Paardekooper, Gabriel M. R. M.
    Patijn, Gijs A.
    van der Sangen, Maurice J. C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    Zwinderman, Aeilko H.
    Punt, Cornelis J.
    van Tienhoven, Geertjan
    van Eijck, Casper H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (11) : 1220 - +
  • [2] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [3] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [4] Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
    Versteijne, Eva
    Suker, Mustafa
    Groothuis, Karin
    Akkermans-Vogelaar, Janine M.
    Besselink, Marc G.
    Bonsing, Bert A.
    Buijsen, Jeroen
    Busch, Olivier R.
    Creemers, Geert-Jan M.
    van Dam, Ronald M.
    Eskens, Ferry A. L. M.
    Festen, Sebastiaan
    de Groot, Jan Willem B.
    Koerkamp, Bas Groot
    de Hingh, Ignace H.
    Homs, Marjolein Y., V
    van Hooft, Jeanin E.
    Kerver, Emile D.
    Luelmo, Saskia A. C.
    Neelis, Karen J.
    Nuyttens, Joost
    Paardekooper, Gabriel M. R. M.
    Patijn, Gijs A.
    van der Sangen, Maurice J. C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    Zwinderman, Aeilko H.
    Punt, Cornelis J.
    van Eijck, Casper H.
    van Tienhoven, Geertjan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (16) : 1763 - +
  • [5] Preoperative Chemoradiotherapy Potentially Improves Outcome for (Borderline) Resectable Pancreatic Cancer: Preliminary Results of the Dutch Randomized Phase III PREOPANC Trial
    Versteijne, E.
    Suker, M.
    Punt, C. J. A.
    Groothuis, K. B.
    Beukema, J. C.
    Bruynzeel, A.
    Buijsen, J.
    Hendriksen, E. M.
    Intven, M. P. W.
    Neelis, K.
    Nuyttens, J.
    Paardekooper, G. M. R.
    Rozema, T.
    Rutten, H.
    van der Sangen, M. J. T.
    Zwinderman, A. H.
    van Eijck, C. H. J.
    van Tienhoven, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (05): : 1606 - 1607
  • [6] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [7] Neoadjuvant Chemotherapy and Radiation Improves Recurrence-free and Overall Survival in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Chandana, Sreenivasa
    Eastburg, Benjamin
    Frisch, Austin
    Parker, Jessica
    Wright, G. Paul
    Assifi, M. Mura
    Chung, Mathew
    AMERICAN SURGEON, 2024,
  • [8] Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer
    Lee, Darren
    Nelson, Bailey
    Rai, Shesh
    Rai, Jayesh
    Wang, Kyle
    Sohal, Davendra
    Olowokure, Olugbenga Olanrele
    Rojan, Adam
    Patel, Sameer H.
    Wilson, Gregory
    Ahmad, Syed A.
    Kharofa, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [10] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
12345